Trial Profile
Phase I Study of PS-341 in Combination With 5-Fluorouracil and External Beam Radiotherapy For The Treatment Of Locally Advanced And Metastatic Rectal Cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Bortezomib (Primary) ; Fluorouracil
- Indications Colorectal cancer
- Focus Adverse reactions
- 13 Feb 2012 Actual patient number (11) added as reported by ClinicalTrials.gov.
- 13 Feb 2012 Actual end date (1 Sep 2010) added as reported by ClinicalTrials.gov.
- 13 Feb 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.